Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy.

Front Endocrinol (Lausanne) · 2017 · PMC5722794 · PMID 29255447

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

This study was discontinued early by the independent ethics review panel because of a high number of serious adverse events and deaths in the placebo arm, and a significant trend toward improvement in PFS in the treatment group ( 58 ).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.